This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Cheong Byeol Shin in Polypeptide Conjugate Preparation
Introduction
Cheong Byeol Shin is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of biochemistry, particularly in the preparation of physiologically active polypeptide conjugates. His innovative methods aim to enhance the efficacy and yield of peptide drugs.
Latest Patents
Cheong Byeol Shin holds a patent for a "Method of preparing physiologically active polypeptide conjugate." This method involves linking a physiologically active polypeptide with a non-peptidyl polymer through a covalent bond. The process is designed to improve the overall yield of the conjugate by optimizing the reaction between the two components. Notably, the method employs a two-step reaction that utilizes selective precipitation to achieve high yields. This innovative approach is particularly beneficial for developing long-acting formulations of peptide drugs, which maintain in vivo activity and significantly increase blood half-life.
Career Highlights
Throughout his career, Cheong Byeol Shin has focused on advancing the field of peptide drug development. His work has been instrumental in creating methods that enhance the stability and effectiveness of peptide-based therapies. His dedication to research and innovation has positioned him as a key figure in his area of expertise.
Collaborations
Cheong Byeol Shin has collaborated with notable colleagues, including Sun Jin Moon and Sung H Hong. These partnerships have contributed to the advancement of research in the field of biochemistry and have fostered a collaborative environment for innovation.
Conclusion
Cheong Byeol Shin's contributions to the preparation of physiologically active polypeptide conjugates represent a significant advancement in the field of biochemistry. His innovative methods not only improve the yield of peptide drugs but also enhance their therapeutic potential.